Reasons to be testing: the dawn of complex molecular profiling in routine oncology practice.

Subjects

Subjects :

Antineoplastic Agents pharmacology
Antineoplastic Agents therapeutic use
Biomarkers, Tumor antagonists & inhibitors
Clinical Trials as Topic
Genetic Testing economics
Humans
Medical Oncology economics
Medical Oncology methods
Neoplasms genetics
Patient Selection
Precision Medicine economics
Precision Medicine trends
Reimbursement Mechanisms
State Medicine economics
United Kingdom
Biomarkers, Tumor genetics
Genetic Testing trends
Medical Oncology trends
Neoplasms drug therapy
Precision Medicine methods

Details

Language :

English

ISSN :

1569-8041

Volume :

30

Issue :

11

Database :

MEDLINE

Journal :

Annals of oncology : official journal of the European Society for Medical Oncology

Publication Type :

Report

Accession number :

31665210

Full Text :

https://doi.org/10.1093/annonc/mdz392